Clarithromycin
Back to searchMolecule Structure
Scientific Name
Clarithromycin
Description of the Drug
Clarithromycin is a macrolide antibiotic used for the treatment of a wide variety of bacterial infections such as acute otitis, pharyngitis, tonsillitis, respiratory tract infections, uncomplicated skin infections, and helicobacter pylori infection.
http://www.drugbank.ca/drugs/DB01211
Brand Name(s)
Biaxin, Biaxin xl, Biaxin Xl Pac, Clarie xl, Clarithromycin, Clarithromycin Extended Release, Clarosip, Febzin xl, Klaricid, Klaricid 500, Klaricid adult, Klaricid i.v., Klaricid paed, Klaricid xl, Mycifor xl, Xetinin xl, Zeclar
Company Owner(s)
Sunshine Lake Pharma Co Ltd, Takeda Pharmaceuticals Usa Inc, Abbvie Inc, Chartwell Life Molecules Llc, Mylan Pharmaceuticals Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Rising Pharma Holdings Inc, Teva Pharmaceuticals Usa Inc, Ajanta Pharma Ltd, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL38125 | ||
| PharmGKB | PA449028 | ||
| Human Metabolome Database | HMDB0015342 | ||
| DrugBank | DB01211 | ||
| PubChem: Thomson Pharma | 14913515 | 14937909 | |
| PubChem | 84029 | ||
| Mcule | MCULE-7168853332 | ||
| LINCS | LSM-5606 | ||
| Nikkaji | J134.033F | ||
| PDBe | CTY | ||
| BindingDB | 50404044 | ||
| EPA CompTox Dashboard | DTXSID3022829 | ||
| LipidMaps | LMPK04000014 | ||
| DrugCentral | 668 | ||
| Brenda | 229297 | 229298 | 22099 |
| ChemicalBook | CB2225614 | ||
| Guide to Pharmacology | 10903 | ||
| rxnorm | BIAXIN | CLARITHROMYCIN | |
| PubChem: Drugs of the Future | 12013874 | ||
| KEGG Ligand | C06912 | ||
| ChEBI | 3732 | ||
| ZINC | ZINC000085534098 |
